{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/LSE/GSK",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# GSK PLC (LSE Main Market: GSK) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is GSK PLC, listed on the LSE Main Market under ticker GSK, ISIN GB00BN7SWP63, LEI 5493000HZTVUYLO1D793. Its security type is Corporate, segment SET1, sector Pharmaceuticals and Biotechnology [201030], jurisdiction England and Wales (Companies House jurisdiction field). Status on the record is listed, not halted.\n\n## The disclosure read\n\nThe record holds 346 filings in the twelve months to 2026-11-06, across 177 filing days. The median gap between filing days is 1.0 days. Days from the latest filing to the record date is 0. The exchange median cadence gap is 4 days and the sector median cadence gap is 6.0 days. The exchange median filings count is 29.0 and the sector median is 42. The exchange median latency is 3 days and the sector median latency is 4.0 days. The latest filing is dated 2026-11-06 and is of type corporate_action.\n\n## Auditor\n\nThe auditor of record is Deloitte LLP. Its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. Status on the halt flag is listed, not halted.\n\n## Orderability\n\nFor the elective professional client category the outcome is signal ACM-200, determinable. For the eligible counterparty category the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.\n\n## Coverage\n\nThe issuer's own investor-relations page names 14 research houses: Barclays, Berenberg, BNP Paribas Exane, Citi, Deutsche Bank, Goldman Sachs, Guggenheim Securities, Jefferies, JP Morgan, Morgan Stanley, Redburn, TD Cowen, UBS and Wolfe Research.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer has no sealed years on the record. The market's vintage is not sealed. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n11 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GSK (identity.isin)\n- https://find-and-update.company-information.service.gov.uk/company/03888792 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/GSK/gsk-plc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/LSE/GSK (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://india-pharma.gsk.com/media/scfg3eux/annual-report-2025-26.pdf (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus (coverage)\n- https://mcp.uk-cm-kg.ai/record/LSE/GSK (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "Tavily regex",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://india-pharma.gsk.com/media/scfg3eux/annual-report-2025-26.pdf",
    "state": "confirmed",
    "value": "Deloitte LLP"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/LSE/GSK",
  "coverage": {
   "count": 14,
   "houses": [
    {
     "house": "Barclays",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Berenberg",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "BNP Paribas Exane",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Citi",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Deutsche Bank",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Goldman Sachs",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Guggenheim Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Jefferies",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "JP Morgan",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Morgan Stanley",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Redburn",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "TD Cowen",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "UBS",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    },
    {
     "house": "Wolfe Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus",
     "result": "read: 14 of 30 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 892,
     "median_cadence_gap_days": 4,
     "median_filings": 29,
     "median_latency_days": 3,
     "name": "LSE Main Market"
    },
    "sector": {
     "issuers": 51,
     "median_cadence_gap_days": 6,
     "median_filings": 42,
     "median_latency_days": 4,
     "name": "Pharmaceuticals and Biotechnology [201030]"
    }
   },
   "by_type": {
    "agm_record_date": 2,
    "ch_accounts_filed": 1,
    "ch_capital": 76,
    "ch_confirmation_statement": 1,
    "ch_officer_change": 3,
    "ch_other": 1,
    "ch_resolution": 2,
    "corporate_action": 108,
    "director_dealing": 75,
    "early_warning": 3,
    "financial_statement": 3,
    "newswire_release": 4,
    "regulatory_announcement": 67
   },
   "cadence_median_gap_days": 1,
   "filing_days": 177,
   "filings": 346,
   "latency_days": 0,
   "latest": [
    {
     "category": null,
     "date": "2026-11-06",
     "source": "https://www.investegate.co.uk/announcement/rns/gsk--gsk/gsk-publishes-provisional-dividend-dates/9863473",
     "title": "GSK publishes provisional dividend dates",
     "type": "corporate_action"
    },
    {
     "category": null,
     "date": "2026-11-06",
     "source": "https://find-and-update.company-information.service.gov.uk/company/03888792/filing-history/MzU1NDczODI3OGFkaXF6a2N4/document?format=pdf&download=0",
     "title": "capital allotment shares — 2026-10-30",
     "type": "ch_capital"
    },
    {
     "category": null,
     "date": "2026-11-03",
     "source": "https://www.globenewswire.com/news-release/2026/11/03/3394760/0/en/alamar-biosciences-partners-with-gsk-on-large-scale-proteomic-study-to-advance-precision-medicine.html",
     "title": "Alamar Biosciences Partners with GSK on Large-Scale",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-11-02",
     "source": "https://www.investegate.co.uk/announcement/rns/gsk--gsk/total-voting-rights/9854006",
     "title": "Total Voting Rights",
     "type": "corporate_action"
    },
    {
     "category": null,
     "date": "2026-10-30",
     "source": "https://find-and-update.company-information.service.gov.uk/company/03888792/filing-history/MzU1MzY1NjMyN2FkaXF6a2N4/document?format=pdf&download=0",
     "title": "capital allotment shares — 2026-10-23",
     "type": "ch_capital"
    }
   ],
   "latest_filing_date": "2026-11-06",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/GSK",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "LSE Main Market"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GSK",
    "state": "confirmed",
    "value": "GB00BN7SWP63"
   },
   "jurisdiction": {
    "read_by": "Companies House REST API (company profile) (jurisdiction field)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/03888792",
    "state": "confirmed",
    "value": "England and Wales (Companies House jurisdiction field)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GB00BN7SWP63)",
    "state": "sourced",
    "value": "5493000HZTVUYLO1D793"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "GSK PLC"
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/GSK/gsk-plc/company-page",
    "state": "sourced",
    "value": "Pharmaceuticals and Biotechnology [201030]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "SET1"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "GSK"
   },
   "website": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/GSK/gsk-plc/company-page",
    "state": "sourced",
    "value": "http://www.gsk.com"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:50c0183e361fd3adb49871b425a7f3a5ac8bc220ccf4b3f91553040d0d0052f3",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/LSE/GSK",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:50c0183e361fd3adb49871b425a7f3a5ac8bc220ccf4b3f91553040d0d0052f3",
 "path": "/uk/LSE/GSK",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is GSK PLC, listed on the LSE Main Market under ticker GSK, ISIN GB00BN7SWP63, LEI 5493000HZTVUYLO1D793. Its security type is Corporate, segment SET1, sector Pharmaceuticals and Biotechnology [201030], jurisdiction England and Wales (Companies House jurisdiction field). Status on the record is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 346 filings in the twelve months to 2026-11-06, across 177 filing days. The median gap between filing days is 1.0 days. Days from the latest filing to the record date is 0. The exchange median cadence gap is 4 days and the sector median cadence gap is 6.0 days. The exchange median filings count is 29.0 and the sector median is 42. The exchange median latency is 3 days and the sector median latency is 4.0 days. The latest filing is dated 2026-11-06 and is of type corporate_action.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Deloitte LLP. Its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. Status on the halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the elective professional client category the outcome is signal ACM-200, determinable. For the eligible counterparty category the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's own investor-relations page names 14 research houses: Barclays, Berenberg, BNP Paribas Exane, Citi, Deutsche Bank, Goldman Sachs, Guggenheim Securities, Jefferies, JP Morgan, Morgan Stanley, Redburn, TD Cowen, UBS and Wolfe Research.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer has no sealed years on the record. The market's vintage is not sealed. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "11 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GSK"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://find-and-update.company-information.service.gov.uk/company/03888792"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/GSK/gsk-plc/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/GSK"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the auditor",
   "source": "https://india-pharma.gsk.com/media/scfg3eux/annual-report-2025-26.pdf"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/LSE/GSK"
  }
 ],
 "title": "GSK PLC (GSK) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}